Annotated Bibliography

Multiple studies referencing SCOPESCREEN products.

Heterogenous spectrum of CFTR gene mutations in Indian patients with congenital absence of vas deferens.

AUTHORS: Sharma N, Acharya N, Singh SK, Singh M, Sharma U, Prasad R.

PUBLICATION: Hum Reprod 2009;24:1229-1236. PUBMED ID: 1918174

ABSTRACT: In this study of men with congenital absence of the vas deferens, FructoScreen® was used to measure semen fructose. As is shown in the figure, seminal fructose was lower in men with bilateral, compared to unilateral, congenital absence of the vas.

Semen analysis and sperm morphology analysis of infertile males.

AUTHORS: Cai L, Zhang B, Tao X, Wang X, Huang S.

PUBLICATION: Medical and Health Care Instruments, 2008;9:64-66.

ABSTRACT: In this report, QC-Beads™ were used for internal quality control in an andrology laboratory. Quality control was done on both a daily basis and with weekly random assessment. 

Comparative concentrations of steroid hormones and proteins in human peri-ovulatory peritoneal and follicular fluids. 

AUTHORS: Munuce MJ, Quintero I, Caille AM, Ghersevich S, Berta CL.

PUBLICATION: Reprod BioMed Online 200613:202-207. PUBMED ID: 16895633

ABSTRACT: Basic researchers used MarScreen® IgA and MarScreen® IgG to measure indirect antisperm antibodies in peritoneal fluid of women undergoing laparoscopy.

Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients.

AUTHORS: Motrich RD, Cuffini C, Obert JPM, Maccioni M, Rivero VE.

PUBLICATION: J Infect 2006;53:175-183. PUBMED ID: 16376990

ABSTRACT: Researchers used ImmunoSpheres® IgA and MarScreen® IgG to study sperm quality in men with chronic prostatitis.

Acrosin activity in spermatozoa of infertile Nigerian males.

AUTHORS: Emokpae MA, Uadia PO.

PUBLICATION: Ind J Clin Biochem 2006;21:199-201. 

URL: http://www.medind.nic.in/iaf/t06/i1/iaft06i1p199.pdf

ABSTRACT: In this cohort study, AcroScreen™ was used to measure acrosin activity in infertile men and controls. Acrosin activity was lower in men with infertility compared to fertile control men.

Testicular microlithiasis and antisperm antibodies following testicular biopsy in boys with cryptorchidism.

AUTHORS: Patel RP, Kolon TK, Huff DS, Carr HM, Zderic SA, Canning DA, et al.

PUBLICATION: J Urology 2005;74:2008-2010. PUBMED ID: 16217379

ABSTRACT:MarScreen® IgG was used to measure antisperm antibodies in young men 10 years after testicular biopsy. In 57 cases, antisperm antibodies were negative in all, offering reassurance against fertility detriments of testicular biopsy.

Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens.

AUTHORS: Motrich RD, Maccioni M, Molina R, Tissera A, Olmedo J, Riera CM, et al.

PUBLICATION: Hum Reprod 2005;20:2567-2572. PUBMED ID: 15890732

ABSTRACT: Researchers used ImmunoSpheres® IgA and Marscreen® IgG in a study of autoimmune responses with chronic prostatitis. Antisperm antibodies were unassociated with chronic prostatitis.

Antisperm antibodies in semen, sera and follicular fluids of infertile patients: relation to reproductive outcome after in vitro fertilization.

AUTHORS: Vujisić S, Lepej SŹ, Jerkovi L, Emedi I, Sokolić B.

PUBLICATION: Am J Reprod Immunol 2005:54:13-20. PUBMED ID: 15948768

ABSTRACT: Leucoscreen® was used to quantify seminal leukocytes. Marscreen® IgA, IgG, and IgM were used to measure antisperm antibodies on sperm surfaces and in peritoneal and follicular fluids of the partners.

Modulation of human sperm function by peritoneal fluid.

AUTHORS: Munuce MJ, Marín-Briggiler CI, Caille AM, Berta CL, Cuasnicú PS, Morisolli L.

PUBLICATION: Fertil Steril 2003;80:939-946. PUBMED ID: 14556816

ABSTRACT: MarScreen® was used to detect indirect antisperm antibodies in this study of peritoneal fluid.

Acrosome activity is lower in sperm from men with spinal cord injury compared to age-matched, healthy control subjects.

AUTHORS: Munuce MJ, Marín-Briggiler CI, Caille AM, Berta CL, Cuasnicú PS, Morisolli L.

PUBLICATION: Fertil Steril 2003;80,s3:s48.

URL:  http://www.fertstert.org/article/S0015-0282%2803%2901932-0/abstract

ABSTRACT: AcroScreen™ was used to measure acrosin activity, which was lower in spinal cord injured men, compared to controls.

Improvement in sperm quality and function with French maritime pine tree bark extract.

AUTHORS: Roseff SJ.

PUBLICATION: J Reprod Med 2002;47: 821-824. PUBMED ID: 12418064

ABSTRACT: ImmunoSpheres® were used to test for direct antisperm antibodies in this observational study of men with subfertility who received treatment with an antioxidant compound.

Birth after intracytoplasmic sperm injection with use of testicular sperm from men with Kartagener/immotile cilia syndrome.

AUTHORS: Cayan S, Conaghan J, Schriock ED, Ryan IP, Black LD, Turek PJ.

PUBLICATION: Fertil Steril 2001;76:612-614. PUBMED ID: 17442314

ABSTRACT: In this case report, ImmunoSpheres® were used to test for indirect antisperm antibodies in an individual with Kartagener’s/immotile cilia syndrome.

Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens.

AUTHORS: Casals T, Bassas L, Egozcue S, Ramos MD, Giménez J, Segura A, et al.

PUBLICATION: Hum Reprod 2000;15:1476-1483. PUBMED ID: 11532490

ABSTRACT: FructoScreen® and CitricScreen® were used to study patients with congenital absence of the vas deferens. Fructose and citric acid concentrations were highly correlated with seminal volume. Fructose concentrations in seminal plasma were higher in men with unilateral, compared to bilateral, absence of the vas deferens.

Advantages of a new kit for the determination of antisperm autoantibodies.

AUTHORS: Solis EA, Gatti VN, Brufman AS, Bouvet BR, Provenzal OC.

PUBLICATION: Arch Esp Urol 2000;53:363-6. PUBMED ID: 10900767

ABSTRACT: TAC II, a novel kit developed and validated by the authors, was compared to Marscreen®. Results were in agreement between methods. TAC II can be used on frozen and oligospermic samples.

Improvement of sperm quality by Pycnogenol®.

AUTHORS: Roseff SJ, Gulati R.

PUBLICATION: Eur Bull Drug Res 1999;7:33-36.

URL: http://www.chiroonline.net/_fileCabinet/pycnog_pub.pdf

ABSTRACT: ImmunoSpheres® were used to test for direct antisperm antibodies in this observational study of men with subfertility who received treatment with an antioxidant compound.

.

Comparison of the immunobead binding test (IBT) and immunospheres (IS) assay for detecting serum antisperm antibodies.

AUTHORS: Centola GM, Andolina E, Deutsch A.

PUBLICATION: Am J Reprod Immunol 1997;37: 300-303. PUBMED ID: 9161636

ABSTRACT: Antisperm antibody results using color coded ImmunoSpheres®, visualized by bright field microscopy, and the Immunobead binding test, visualized by phase contrast microscopy, were in agreement.

The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia.

AUTHORS: Adamopoulos DA, Nicopoulou S, Kapolia N, Karamertzanis M, Andreou E.

PUBLICATION: Fertil Steril 1997;67:756-762. PUBMED ID: 9093207

ABSTRACT: AcroScreen™ was used to measure acrosin in this randomized trial of hormonal therapy for men with idiopathic oligozoospermia.

Total acrosin activity correlates with fertility potential after fertilization in vitro.

AUTHORS: Tummon IS, Yuzpe AA, Daniel SAJ, Deutsch A.

PUBLICATION: Fertil Steril 1991;56:933-938. PUBMED ID 1936330

ABSTRACT: The total acrosin activity index measured with AcroScreen™, then described as AccuSperm, is greater when fertilization in vitro is successful, compared to when it is not.

A simplified method for measuring acrosin activity in spermatozoa.

AUTHORS: Deutsch A, Prisco J, Melnick H, Vescell TA, Ionascu L, Williams W.

PUBLICATION: J Int Fed Clin Chem 1990;2:228-231

ABSTRACT:  The original description of AcroScreen™, the simplified photometric method for measuring acrosin activity.